Mstack’s Chemstack uses AI and Bayesian optimisation to cut chemical synthesis from 18 months to days, boosting supply-chain resilience and diversification.

Loading the Elevenlabs Text to Speech AudioNative Player...
While chemical companies frantically announce supply chain diversification plans, one company quietly achieved something that seemed impossible: reducing molecular synthesis development from 18 months to days while posting 10x revenue growth during a supply chain crisis. The apparent contradiction reveals something most executives miss entirely – the real bottleneck preventing supply chain diversification isn’t factories or logistics. It’s knowledge.
Mstack‘s breakthrough comes at a moment when the chemical industry faces an uncomfortable truth. Despite obvious geopolitical risks and tariffs reaching 10-50% on critical intermediates, companies remain trapped in vulnerable supply chains because the specialised synthesis expertise needed for alternatives lives in the heads of a few dozen chemists scattered across global competitors.
Supply chain disruptions have escalated dramatically, but the focus on manufacturing capacity misses the deeper structural problem. Chemical supply chain failures often result from bottlenecks linked to the concentration of specialised synthesis knowledge rather than simple capacity constraints. The industry has become bifurcated between massive commodity producers optimised for scale and small specialty companies with deep but narrow expertise – neither capable of rapidly scaling new methods across chemical domains.
This knowledge concentration creates what economists call a ‘missing middle’ problem. Large players like BASF or Dow can manufacture massive volumes efficiently but struggle to develop new synthesis routes quickly. Meanwhile, specialty firms possess the expertise but lack the infrastructure to scale alternatives rapidly when geopolitical tensions flare.
The Texas Gulf Coast demonstrates this vulnerability perfectly. The region hosts the world’s largest concentration of petrochemical facilities, but when Hurricane Harvey hit in 2017, the entire global supply of certain specialty chemicals halted not because refineries flooded, but because the handful of experts who knew how to restart complex synthesis processes were temporarily inaccessible. Similar where specialized knowledge creates single points of failure.
Subscribe to our newsletter and never miss a story. No spam, ever.

Ukrainian drones have destroyed 11,000 Russian tanks. Rheinmetall has not built a single new one. Its CEO says the Ukrainians are the ones who lack innovation.

A forgotten mine in Cornwall's Tamar Valley has just been valued at over £1 billion after drilling revealed far more tungsten, tin and silver than anyone expected. With China choking off 80% of global tungsten supply, the timing could not be sharper.

Labour's UK EU deal delivers frictionless trade outside the single market. You would think the Brexiteers would be thrilled. They are furious (shock horror).
Mstack’s Chemstack AI platform attacks this problem through three integrated modules that essentially convert scarce human expertise into software. LiteratureIQ maps vast datasets of chemical literature into comprehensive knowledge graphs, turning decades of scattered research into searchable intelligence. MSTACK RetroRank generates and ranks viable synthetic routes with 98.6% exact match recall and 72.6% Top-1 accuracy – metrics that outperform traditional approaches by significant margins.
But the real breakthrough lies in Experimentation Assist, which uses Bayesian Optimisation to intelligently navigate reaction configurations. This creates what Mstack calls ‘closed-loop validation between AI insights and laboratory outcomes’ – essentially mimicking how master chemists intuitively adjust reactions based on experimental feedback.
The technical specifications matter because they demonstrate something unprecedented: AI systems achieving expert-level performance in chemical synthesis, a domain previously thought too complex and intuitive for automation. This mirrors broader trends in strategic decision AI achieving hallucination-free superintelligence across specialized domains. Traditional chemical companies still follow development timelines that typically span 12 to 18 months from route scouting through scale-up preparation.
Mstack’s 10x revenue growth and expansion to over 100 enterprise customers across North America, India, China and the Middle East provides concrete evidence that companies will rapidly adopt alternatives when they become available. Large agrochemical companies have already transitioned procurement from Chinese suppliers to Mstack as their preferred partner – a remarkable switch given the industry’s traditional conservatism.
The company’s success in the Indian agrochemicals market demonstrates the broader implications. Enhanced supply predictability through local manufacturing eliminates cross-border logistics uncertainties, while AI-optimised synthesis routes deliver more consistent product specifications at lower costs through improved yields. These advances parallel real-time supply chain decision platforms transforming operational precision across industries.
‘We’re not just another chemical company – we’re fundamentally redefining what’s possible when AI becomes the world’s smartest chemist,’ said Shreyans Chopra, Mstack’s founder. ‘Our growth trajectory demonstrates that the market desperately needs alternatives, and traditional players simply can’t develop synthesis routes at the speed and scale necessary to create viable options.’
This represents something bigger than supply chain diversification. AI has already democratised access to specialised knowledge across domains from medical diagnosis to financial analysis. Mstack’s approach suggests chemistry might be next, potentially breaking open an industry structure that has resisted change for decades.
The company’s asset-light marketplace model allows seamless onboarding of suppliers from the USA, Middle East, Southeast Asia and Korea. This approach proves particularly valuable during macro-economic volatility, providing customers cost-effective alternatives while maintaining quality standards without requiring massive capital investments typical of traditional chemical expansion.
Their upcoming Chemistry World Model promises to push this further, potentially enabling organisations of all sizes to access breakthrough discovery capabilities previously available only to the largest pharmaceutical and chemical companies. The platform aims to unlock synthesis of complex molecules, expanding the boundaries of what’s chemically and commercially feasible. Similar advances in persistent memory AI systems are enabling more sophisticated knowledge retention across specialized sectors.
The broader implications extend beyond just supply chain resilience. When specialised knowledge becomes software rather than scarce human capability, entire industry structures can shift rapidly. AI co-scientists are already helping generate novel hypotheses and accelerate breakthroughs across scientific domains, suggesting we’re witnessing the early stages of a fundamental shift in how technical discovery happens.
For an industry built on institutional knowledge accumulated over decades, the prospect that AI might democratise access to world-class synthesis expertise represents either the greatest opportunity or the greatest threat companies have faced in generations. Industries from pharmaceutical manufacturing to compliance-driven sectors are already witnessing similar AI-powered transformations. Mstack’s rapid growth suggests the market has already decided which it prefers.